Law360 reports (subscription) that Johnson & Johnson received a $70 million verdict on a Philadelphia Risperdal injury case where side effectsd of the widely-prescribed antipsychotic drug caused an adolescent boy to grow prominent breasts. This verdict is significantly higher than other recent Pennsylvania Risperdal injury judgments against J&T over allegations that the drug caused breast growth.
The Risperdal cases focus on allegations that the drug manufacturers worked to blur evidence that Risperdal was linked to abnormal development of breast tissue in adolescent boys, a condition known as gynecomastia. The cases make claims that while warning labels for the medication indicated that gynecomastia was a rare side effect that occurred in fewer than one in 1,000 patients, company scientists that Risperdal was associated with spikes in prolactin, a hormone known to be related to the development of gynecomastia.
Contact Lieff Cabraser
If you or a family member has developed gynecomastia after being prescribed Risperdal, you may be eligible to file a claim.
Please visit our Risperdal injuries page to contact Lieff Cabraser for a free, prompt, and confidential evaluation of your case, with no obligation on your part.
About Lieff Cabraser
Recognized as “one of the nation’s premier plaintiffs’ firms” by The American Lawyer, Lieff Cabraser Heimann & Bernstein, LLP is a sixty-plus attorney law firm with offices in San Francisco, New York, and Nashville. Our firm has successfully represented thousands of patients across America in individual lawsuits due to the injuries they suffered from dangerous prescription drugs with undisclosed side effects.
U.S. News and Best Lawyers have named Lieff Cabraser as their 2015 “Law Firm of the Year” for representing plaintiffs in class actions and mass torts. Law360 has recognized Lieff Cabraser with its practice group of the year award for the successes we have achieved for our clients in personal injury and mass torts cases.